DESCRIPTION

Colace® (docusate sodium) is a stool softener product

Active Ingredient:    Colace® Capsules 50 mg. contains 50 mg of docusate sodium

Inactive Ingredients:    D&C Red No. 33, FD&C Red No. 40, gelatin, glycerin, polyethylene glycol 400, propylene glycol, sorbitol

USES

Relieves occasional constipation (irregularity). Generally produces a bowel movement in 12 to 72 hours.

WARNINGS

Do not use if you are presently taking mineral oil, unless told to do so by a doctor. Ask a doctor before use if you have stomach pain, nausea, vomiting, or noticed a sudden change in bowel habits that lasts over 2 weeks. Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition. Stop use and ask a doctor if you need to use a laxative for more than 1 week. If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE

doses may be taken as a single daily dose or in divided doses
adults and children 12 years and over
take 1-6 capsules daily
children 2 to under 12 years of age
take 1-3 capsules daily
children under 2 years
ask a doctor

Other information

Each capsule contains sodium 3 mg.

VERY LOW SODIUM

store at 25°C (77°F); excursions

permitted between 15°-30°C (59°-86°F).

HOW SUPPLIED

Capsules:    Boxes of 10. Bottles of 30 and 60.

Copyright 2003, 2004, Purdue Products L.P., Stamford, CT 06901-3431     

www.colacecapsules.com

PRODUCT PHOTO(S):

NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.

The product samples shown here have been supplied by the manufacturer and reproduced in full color by PDR as a quick-reference identification aid. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected overdosage, the drug's identity should be verified by chemical analysis.

images/pills/n05515c2.jpg
images/pills/p06330e1.jpg



Copyright© 2006 Thomson PDR